Innovation in Healthcare
Innovation in Healthcare
A PROJECT REPORT ON
INNOVATION IN HEALTHCARE
SUBMITTED BY
MR. ABHISHEK NANDALAL MISHRA
ROLL NO: 166030
M.Com. SEM- III
(ADVANCE ACCOUNTANCY)
ACADEMIC YEAR: 2016-17
INNOVATION IN HEALTHCARE
Date:
Signature
Place:
INNOVATION IN HEALTHCARE
CERTIFICATE
I, Prof. M. S. GANAGI, hereby certify that MR. ABHISHEK NANDALAL MISHRA
R.No. 166030 of Mulund College of Commerce, S. N. Road, Mulund (West), Mumbai
-400080 of M.com Part II (Advanced Accountancy) has completed her project on
INNOVATION IN HEALTHCARE during the academic year 2016-17. The information
submitted is true and original to the best of my knowledge.
____________________
___________________
Project Guide
External guide
_____________________
___________________
Co-coordinator
Principal
Date:
ACKNOWLEDGEMENT
INNOVATION IN HEALTHCARE
PLACE:
Signature
DATE:
INNOVATION IN HEALTHCARE
INDEX
ABSTRACT..........................................................................................................................................7
OBJECTIVES.......................................................................................................................................9
INNOVATION IN HEALTHCARE: WHY ITS NEEDED.................................................................10
TRENDS SHAPING THE HEALTHCARE INDUSTRY...................................................................13
TECHNOLOGICAL INNOVATIONS IN HEALTHCARE.................................................................17
INNOVATION IN HEALTHCARE DELIVERY SYSTEM................................................................24
INNOVATION IN MARKETING STRATEGIES...............................................................................29
CHALLENGES IN INNOVATION IN HEALTHCARE INDUSTRY................................................32
RECOMMENDATION FOR INNOVATIVE AND SUSTAINABLE HEALTHCARE.......................34
CONCLUSION...................................................................................................................................36
REFERENCES....................................................................................................................................37
INNOVATION IN HEALTHCARE
INNOVATION IN HEAL
INNOVATION IN HEALTHCARE
ABSTRACT
The healthcare industry has experienced a proliferation of innovations aimed at enhancing
life expectancy, quality of life, diagnostic and treatment options, as well as the efficiency and
cost effectiveness of the healthcare system. Health care organizations are finding their own
moments of truth where they engage in new thinking about their customers. Whether these
moments are prompted by inspiration from other industries, competition, health reform,
consumer demands or the bottom line, agile companies are changing the way they get to
know their customers, moving beyond basic transactions and embracing their patients.
Several service industries outside of healthcare are helping shape healthcare consumer
experiences and expectations. Todays technologically savvy consumers are more apt to do
their own research when selecting a doctor, investigating treatment options, and making
major health care decisions. Targeted marketing also enables us to tailor communications to
each stage of the member relationship. In this project I will inspect such Innovations in the
healthcare sector Globally and in the Indian economy.
In healthcare, the term innovation has traditionally been reserved for the development of
new therapies, drugs, or medical devices. As both private and public efforts to reform the
healthcare system gain momentum, it is clear that innovation must be explored in a broader
context, one that examines previously underdeveloped opportunities in areas such as data
analytics, consumer behaviour, provider incentives, and process improvement in care
delivery.
This project highlights the Technological Innovations in Healthcare, Innovations in the
Marketing Strategies, Innovation in Healthcare Delivery system, Financing and Costing of
Healthcare, Innovation and Development in Indian Healthcare, and the Challenges in
Innovation in Healthcare Industry and Recommendation for Innovative and Sustainable
Healthcare.
INNOVATION IN HEALTHCARE
Healthcare, of course, has more than its share of very complex questions. How can we
reduce costs and increase value, improve patients experiences and outcomes, speed the
translation of research into therapies and cures, make healthcare something that people can
have access to here in the United States, and, ultimately, around the world? If we widen the
boundaries of inquiry to address questions of this sort, we discover the importance of
collaborations and partnerships across the industry and across the related academic fields.
In spite of all the dramatic enhancements in digital connectivity and communication, there is
something uniquely powerful and generative about bringing thinkers and doers together to
interact in person.
INNOVATION IN HEALTHCARE
OBJECTIVES
The objective of this study is to identify:
INNOVATION IN HEALTHCARE
1990-2007
10
8
1.4
6
4
Axis Title
7.6
7.2
2
1.2
-0.6
0
-2
-2.3
-0.7
-0.8
-4
10
INNOVATION IN HEALTHCARE
11
INNOVATION IN HEALTHCARE
and additional creative technology-enabled options for effective health encounters (e.g.,
patient to provider, provider to provider, and patient to patient).
Over the past two decades, innovation has become critical to economic growth and progress
in all industries. To the casual observer, technology-induced innovation can seem random and
linear, but if one stands back, a more dramatic pattern becomes apparent. The pace of
innovation is accelerating exponentially and often is exogenous to the economy.
Entrepreneurs and scientists do not think or create more slowly during recessions. Innovation
is often easier during downturns and difficult times.
When it comes to health care service delivery, patients, payers, and politicians are asking for
improved results: better access, faster diagnosis and treatment, more convenience, greater
sensitivity to cultural differences and health disparities, and so on. But if we continue to do
what we've always done, we will get the results we have always gotten. Nor is it enough to
merely pursue incremental improvement. The challenges we face today call for more novel
approaches in other words, innovation.
12
INNOVATION IN HEALTHCARE
13
INNOVATION IN HEALTHCARE
32%
30%
25%
20%
16%
15%
10%
5%
0%
2013
2015
MEDICAL TOURISM
Percentage of consumers who are willing to make the following trade-offs to receive services
from a health system recognized as best in field.
14
INNOVATION IN HEALTHCARE
15
INNOVATION IN HEALTHCARE
Behavioural health will be a key issue in 2016, as one out of five American adults
experiences a mental illness every year. These conditions cost businesses across the nation
more than $440 billion annually. Employers and healthcare organizations may address
behavioural healthcare to keep costs down, productivity up and consumers healthy.
CARE MOVES TO THE COMMUNITY
Reducing health costs has been part of the healthcare conversation for years. But with
mounting budget pressures, health systems in 2016 may pursue lower-cost care settings more
aggressively and creatively than before. For instance, in the past 24 months, five out of the
top 15 academic medical centres have acquired community hospitals.
PwC's HRI also estimates the rise of retail clinics will continue next year. Seventy-four
percent of clinicians surveyed believe these types of non-traditional venues improve access to
care. Sixty-seven percent of consumers who have used retail clinics were "very satisfied"
with their experience.
16
INNOVATION IN HEALTHCARE
So these are the various trends in the Healthcare Industry, now lets go deeper into the various
Innovations that will drive these trends and shape a sustainable healthcare industry.
17
INNOVATION IN HEALTHCARE
18
INNOVATION IN HEALTHCARE
People include patients, providers (physicians/hospitals), business sponsors, end users, claim
processors, clinical staff, clearing houses, software vendors audit/compliance personnel,
underwriters, policy makers, plan sponsors/employers, insurance agents/ brokers, etc.
Technology includes insurance company systems (member enrolment systems, plan sponsor
information maintenance system, insurance product system, claim processing engines, patient
management systems, provider services systems, patient/plan sponsor support applications,
etc.); provider systems (physician systems, hospital management applications); vendor
systems to submit claims on behalf of providers; government systems to regulate healthcare
industry and perform audits of insurance companies and providers, etc.
Process includes member enrolment process, underwriting process, insurance product setup
process, claim processing, claim submission process, claim intake process, patient services
process, hospital management processes, etc.
In the current state business where there are overlapping industries, technologies depend on
each other. One innovation is dependent on another. Most of the times industries do not factor
in the technological progresses while evaluating other technologies. For example, EMRs in
healthcare cannot happen until the infrastructure is improved in terms of storage and
performance. One innovative idea that might have seemed impossible at one point in time
might become a reasonable commercial product with technological advancements in a couple
of years as a result of other complementary innovations. Often the impact of an innovation
depends on complementary inventions.
Below are some of the technological innovation in the healthcare industry.
DIAGNOSTIC TECHNOLOGIES
The health care industry is amenable to disruptive innovation because the technologies,
business models and potential value networks capable of driving that innovation are already
in place.
Old-fashioned medicine relied on the intuition of costly specialists who had extensive
training and lengthy experience, enabling them to recognize patterns and intuitively arrive at
diagnoses. However, new technologies now make it possible to pinpoint the causes of a
disease through imaging, molecular biology and other diagnostic approaches, thus replacing
19
INNOVATION IN HEALTHCARE
intuitive medicine with precision medicine. In the past, treating diseases was a more
profitable business for pharmaceutical companies and health care providers than diagnosing
them. In the future, that could very well change. Diagnostics probably will come to the fore.
Diagnostic technologies have already changed the treatment of most infectious diseases from
intuitive to precision medicine. In recent years, the emergence of molecular diagnostics and
imaging diagnostics has made medical diagnosis and treatment even more precise. Advances
in genomics and proteomics promise even greater precision, as well as personalization, of
clinical diagnoses and treatments.
ADVANCES IN INFORMATION/COMMUNICATIONS TECHNOLOGIES
The second technological enabler, advances in ICT, not only supports precision medicine by
enabling the development of increasingly precise techniques and devices and the capture and
integration of clinical data for research purposes. They also facilitate the codification,
continuous updating, and diffusion of precision therapies or best-practice care protocols
based on advancing medical knowledge.
ICT can make feasible the integration of a patients health care data with a continuously
advancing medical evidence base to provide real-time medical decision support to
professional care providers, as well as to patients and their families. ICT also enables the
collection, integration, and analysis of data on the performance of the overall system and
supports the use of many advanced systems design, analysis, and governance tools and
methods to improve system performance.
PERSONAL HEALTH RECORD (PHR)
Since 1960, efforts have been made to encourage the use of electronic records, but
implementation has been limited mostly to integrated multispecialty group practices. One of
the most promising disruptive information technologies, the personal health record (PHR),
has advanced efforts to put electronic medical records in place throughout the health care
system. Omid Moghadam, director of PHR programs at Intel, describes a PHR as a record
owned and controlled by the patient that incorporates data the patient enters, but also
includes authenticated information from all of the places the patient is involved with
insurance company, hospital, doctors offices, labs, and so forth (Harvard Medical School,
2006).
20
INNOVATION IN HEALTHCARE
Some companies have already adopted PHRs for their employees, and some insurers are
using them to try to retain customers. Even Microsoft and Google are competing for PHR
business. The hope is that by bringing together an individuals medical information from all
relevant sources, that individual will be in a better position to manage and control his or her
medical care. Widespread use of PHRs could create an informed consumer base that can
begin to buy health services directly, rather than through third parties. PHRs are diffusing
very rapidly from academic environments to academic-corporate-consortium partnerships,
and recently to the commercial world (e.g., Microsoft HealthVault).
DEVELOPMENTS IN TECHNOLOGY ENABLED CARE SERVICES
Connected health or technology-enabled care (TEC) is the collective term for telecare,
telehealth, telemedicine, mHealth, digital health and eHealth services. TEC involves the
convergence of health technology, digital media and mobile devices and is increasingly seen
as an integral part of the solution to many of the challenges facing the health, social care and
wellness sectors, especially in enabling more effective integration of care. TEC uses
connected, medical devices to deliver quality healthcare and includes software, such as health
applications, and hardware including mobile diagnostics, remote monitoring devices and
wearables.
Globally, there are cultural and regulatory barriers to the adoption of TEC, the extent of
which varies from country to country. However, the increasing capability and decreasing
costs of the technology means that financial barriers are becoming less of a concern.
There is a growing body of research showing that TEC, in particular mobile and digitally
enabled technology, has the potential to reduce healthcare costs, increase access and improve
outcomes. The power and reach of the technology can improve access, overcome geographic
distance and shortages of HCPs, while providing a more versatile and personalised approach
to healthcare.
mHEALTH
Digital and mobile health (mHealth) have a wide range of uses, from chronic care
management to complex population health analysis. As healthcare shifts towards a patientcentred, outcome-based delivery model, mHealth will be an important partner in healthcare
transformation. The success of this partnership, however, will be the willingness of key
stakeholders to embrace mHealth. There is also a need for a robust business case to convince
21
INNOVATION IN HEALTHCARE
commissioners and providers that their involvement and investment in the technology is
worthwhile.
22
INNOVATION IN HEALTHCARE
CONNECTED PATIENTS
Mobile technologies can empower patients and carers by giving them more control over their
health and social care needs and reducing their dependence on HCPs for information about
their health.
Technological advancement can help:
adherence
tackle areas of high unmet need that traditional approaches have struggled to address,
23
INNOVATION IN HEALTHCARE
24
INNOVATION IN HEALTHCARE
Nearly all nations are working to improve their healthcare delivery systems. The growth of
chronic illness and aging populations, in particular, has placed a substantial burden on
healthcare systems in both developed and developing countries. For example, 60 percent of
all deaths worldwide (25 million people) are due to chronic illness. Eighty percent of these
occur in low and middle-income countries, and deaths due to chronic illness are double the
number due to infectious diseases. Chronic illnesses also have a huge economic impact. For
example, over the next ten years, chronic illness will result in $558 billion of costs as well as
lost productivity in China; $237 billion in India; and $33 billion in the United Kingdom. In
the US, nearly three-quarters of Americans over the age of 65 suffer from a chronic illness
and half of them have more than one chronic illness. Chronic illness in the United States
accounts for 75 percent of the $2.4 trillion of healthcare expenditures.
To address the above challenge, the healthcare delivery system is experiencing reform
initiative by moving away from the fee-for-service payment model to a capitation payment
model based on a set dollar amount per enrolled subscriber either in total or per selected
conditions; bundled payments comprising a single payment to both physicians and hospitals
for specific procedures or conditions such as coronary artery bypass graft surgery and
rewards or bonuses for achieving predetermined quality outcomes such as reducing
preventable hospital readmissions. At the same time, the United States is experimenting with
new organizational forms potentially able to respond to the new payment incentives.
Lets discuss three such innovations
These three are selected because of their potential for providing more cost effective disease
prevention and management of patients with chronic illness. They are also selected because
of their potential to build on and reinforce each other as a coherent, sustainable package of
delivery system improvements.
25
INNOVATION IN HEALTHCARE
One response to the current lack of coordinated care for patients with chronic illness is the
Patient-centred Medical Home. It provides patients with a primary care physician and a team
that can deliver personalized, whole person, coordinated care across conditions, episodes of
care, different providers and settings over time. It has been widely endorsed and supported by
numerous professional organizations in the US and worldwide.
The four key elements of the PCMH are:
For a given population of patients, a PCMH provides continuous access to a primary care
provider (which can include a nurse practitioner or physician assistant) and a care team
guaranteeing first contact care. Patient-centred care recognizes the patient as the most
important member of the care team. As such, the PCMH empowers patients and their families
as active participants in the care process, partnering with them to understand and address
their needs and preferences. New Model practice involves the adoption of electronic health
records; implementation of the chronic care model including use of disease registries,
guidelines, and patient self-management support programs; and active participation in
continuous quality improvement initiatives. These tools enable the PCMH to track patient
referrals, treatments, and information across providers. To undertake the expanded
responsibility for actively coordinating care across the continuum of patient care, PCMHs
would be paid a care coordination fee in addition to being eligible for additional income from
participation in pay-for performance programs and sharing in savings from providing care for
less than established expenditure targets.
26
INNOVATION IN HEALTHCARE
Accountable Care Organizations are entities that accept responsibility for both the cost and
quality of care provided to a defined population of patients and provide the data on
performance. Along with the PCMH, ACOs are considered to be key elements of delivery
system reform, slowing the rate of increase in spending over time and providing more cost
effective care to the population. ACOs typically include physician practices and at least one
hospital, and could also include nursing homes, home health agencies, and other provider
organizations. They provide the umbrella organization for PCMHs, specialty practices,
hospitals, and other healthcare entities. They are particularly well suited for accepting
capitation, partial capitation, specific episodes-of-care based, and bundled payments. In these
payment mechanisms, the target levels of spending for the ACO would be established based
on several years of prior data, adjusted for risk and overall inflation. Those ACOs that
succeed in delivering care that meets or exceeds quality criteria for less than the expenditure
target would be eligible to share in the savings. This creates economic incentives for
hospitals, physicians, and other providers to work together to prevent unnecessary emergency
room visits, intensive care hospitalizations, and repeat hospitalizations. Key components of
ACOs are their local accountability for cost and quality, the ability to measure their
performance, and the ability to create shared savings.
The ACO is not a uniform one size fits all concept. There are at least five different models
of delivery that could serve as an ACO. These include the integrated or organized delivery
system, multi-specialty group practices, physician hospital organizations, independent
practice organizations, and virtual physician organisations.
Key to the success of the ACO model is the importance of measurement, the backbone for
accountability. This involves specifying the types and level of measures used, the focus of
measurement, and the focus of the provider. In the ACO model, the level of measurement
moves to the entire system or population of patients enrolled in or assigned to the ACO. By
placing measurement at the population level, the hope is that fragmentation will be reduced
and that care will be assessed at the population level across all patients over time. In regard to
the type of measurement, the current emphasis is on process measures of care such as
adherence to guidelines and recommended testing. In the ACO model, emphasis moves to
looking at outcomes measures of care such as reduced disability days, functional health status
scores and patient experience measures as well as overall efficiency of the care provided. The
hope is that this will provide better data for patients to make choices about providers and
27
INNOVATION IN HEALTHCARE
better data for providers to make changes in their practices including increased accountability
for resource use.
Given this measurement focus and the implementation of new payment incentives such as
capitation, partial capitation, and bundled payments, ACOs can potentially provide more cost
effective care utilizing a number of mechanisms. These include expanded use of nurse
practitioners and physician assistants; reducing waste by eliminating duplicate testing through
a focus on internal process of improvement; providing full implementation of chronic care
model disease management processes including patient self-support.
THE POPULATION HEALTH MANAGEMENT SYSTEM
To improve the health of populations and reduce the per capita cost of healthcare, all nations
will need to go beyond improvements in the performance of their healthcare delivery systems
to embrace the broader determinants of health. This will involve the development of crosssector organizations or networks that collectively take responsibility for population health.
As shown in Figure below, the PHMS draws together all of the community health-building
assets (the education sector, transportation sector, etc.) to enhance population health with the
goal of keeping as many people as possible chronically well. Payment is made to the
PHMS based on its achievement of predetermined population health measures.
The organizational form of the PHMS can vary depending on local circumstances. However,
the key is that it would be publicly accountable to local, state, and national governmental
bodies. The core responsibility of the PHMS entity is to:
assess the health status of the community and develop a resulting set of priorities for
28
INNOVATION IN HEALTHCARE
29
INNOVATION IN HEALTHCARE
30
INNOVATION IN HEALTHCARE
even have Ti Vo which record their favourite programme without TV ads, that means todays
customer can block all the possible channels to reach them.
Todays healthcare landscape is a challenging arena. Organizations are in search of successful
and sustainable innovation strategies differentiate from the competition and create viable
solutions that offer improved healthcare experiences for patients and care providers in the
short to longer-term. At the same time the financial system needs to be sustainable. Many
challenges in healthcare demand a diverse mix of skills, knowledge and competences which
is beyond the capability of most individual businesses. Companies therefore have to think in
terms of new models of innovation that include partnerships, acquisitions or strategic
alliances equip themselves for the healthcare challenges ahead. As the presence &
competition of healthcare industry increases with each passing day it is a need of the hour to
adopt innovative strategies from non-healthcare industry to create a unique identity & an
edge over others keeping in mind consumer sensitivity & emotional response.
LEARNING FROM NON HEALTHCARE INDUSTRY
The healthcare industry is facing paradigm change. Within this context of paradigm change
lays opportunities for innovation. Applying non healthcare marketing strategies smartly in
hospital organization will help in enhancing the brand image. The belief that a monumental
problem can be solved by introducing a single tactical element- a brochure, a billboard, a
radio campaign is like the same traditional approach where patients asks for a prescription
without being seen by the doctor and that can be made and successfully implemented. What
needs to be done is to go beyond the currents practices and explores the marketing
opportunity in non-healthcare field.
USE OF MEDICAL VENDING MACHINE IN HEALTHCARE SECTOR
There are much availability of consumables vending machines in several metro stations and
public places. Medical vending machines can be introduced in different metro stations,
railway stations, airports and satellite clinics. The vending machine can be equipped with
mini first aid kits consist of small antiseptic liquid bottle, cotton bowls, bandages, pain relief
tablets, ORS packets, baby care products and more. Medication-dispensing kiosks could be
the next step in the hybrid of health care and self-service. U S Food and Drug Administration
(FDA) recently held public hearings on whether consumer should be able to use patient
kiosks or other technology to conduct self-screenings and obtain certain medications that
currently require prescriptions. FDA is still in early stages of considering such a change.
31
INNOVATION IN HEALTHCARE
Patients already use kiosks to test their blood pressure, check-in for a doctors appointment,
and learn about health problems. Now, prescription medicine dispensing systems are the
next step in user-friendly health care. Medical Vending machine is to go on trial in the UK
which will offer medicines at any time of the day or night. Their arrival in Britain has been
supported by the UK Government and Department of Health. The trial using the machines in
UK hospitals will be assessed by a British university. Its sophisticated technology means it
can dispense drugs whether or not they need to be counted, packed or refrigerated. It is bolted
to a concrete plinth and surrounded by plate steel to protect it against thieves. The machines
are already on trial in Canada, where the government is taking drastic steps to cut down the
cost of prescribing medicines. However, in contrast to many kiosk manufacturers that are
trying to enter this emerging industry, one of the supplier designed such vending machine
system which does not allow patients to self-diagnose, nor does it take the pharmacist out of
the process, which is two of the biggest hurdles now facing the FDAs implementation of
similar technology. The customer can pick up their medicine at their convenience through the
self-service system by swiping their authorization card and placing their index finger on a
scanner. Once the patients identity has been verified, a lockbox door opens and they can
access their medicine.
MARKETING ON SOCIAL MEDIA
Facebook and Twitter, the largest social media Web sites, have more than 350 million users
worldwide, and surveys indicate that 60% of Americans turn first to the Internet when
seeking health-related information. It is therefore surprising that the pharmaceutical and
medical-device industries have been slow to establish a social media presence. The drug
industry allocated less than 4% of the more than $4 billion it spent on direct-to-consumer
advertising to Internet outlets in 2008, and only a tiny fraction of that was for social
networking sites.
Social media brings a new dimension to health care as it offers a medium to be used by the
public, patients, and health professionals to communicate about health issues with the
possibility of potentially improving health outcomes. Social media is a powerful tool, which
offers collaboration between users and is a social interaction mechanism for a range of
individuals. Although there are several benefits to the use of social media for health
communication, the information exchanged needs to be monitored for quality and reliability,
and the users confidentiality and privacy need to be maintained.
32
INNOVATION IN HEALTHCARE
33
INNOVATION IN HEALTHCARE
Health care in most other developed countries is ailing and in need of help. Yes, medical
treatment has made astonishing advances over the years. But the packaging and delivery of
that treatment are often inefficient, ineffective, and consumer unfriendly.
The well-known problems range from medical errors, which by some accounts are the eighth
leading cause of death in the United States, to the soaring cost of health care. The amount
spent now represents about one-sixth of the U.S. gross domestic product; it continues to grow
much faster than the economy; and it threatens the economic future of the governments,
businesses, and individuals called upon to foot the bill. Despite the outlay, more than 40
million people have no health insurance.
Such problems beg for innovative solutions involving every aspect of health careits
delivery to consumers, its technology, and its business models. So why is innovation so
challenging in health care? Its because of these six forces which either help or hinder efforts
at innovation, Individually or in combination.
PLAYERS
The health care sector has many stakeholders, each with an agenda. Often, these players have
substantial resources and the power to influence public policy and opinion by attacking or
helping the innovator. For example, hospitals and doctors sometimes blame technologydriven product innovators for the health care systems high costs. Medical specialists wage
turf warfare for control of patient services, and insurers battle medical service and technology
providers over which treatments and payments are acceptable. Inpatient hospitals and
outpatient care providers vie for patients, while chains and independent organizations spar
over market influence. Non-profit, for-profit, and publicly funded institutions quarrel over
their respective roles and rights. Patient advocates seek influence with policy makers and
politicians, who may have a different agenda altogether namely, seeking fame and public
adulation through their decisions or votes.
FUNDING
Innovation in health care presents two kinds of financial challenges: funding the innovations
development and figuring out who will pay how much for the product or service it yields.
One problem is the long investment time needed for new drugs or therapies that require FDA
approval. While venture capitalists backing an IT start-up may be able to get their money out
34
INNOVATION IN HEALTHCARE
in two to three years, investors in a biotech firm have to wait ten years even to find out
whether a product will be approved for use. Another problem is that many traditional sources
of capital arent familiar with the health care industry, so its difficult to find investors, let
alone investors who can provide helpful guidance to the innovator.
POLICY
Government regulation of health care can sometimes aid innovation (orphan drug laws
provide incentives to companies that develop treatments for rare diseases) and sometimes
hinder it (recent legislation in the United States placed a moratorium on the opening of new
specialty hospitals that focus on certain surgical procedures). Thus, it is important for
innovators to understand the extensive network of regulations that may affect a particular
innovation and how and by whom those rules are enacted, modified, and applied.
TECHNOLOGY
As medical technology evolves, understanding how and when to adopt or invest in it is
critically important. Move too early, and the infrastructure needed to support the innovation
may not yet be in place; wait too long, and the time to gain competitive advantage may have
passed.
CUSTOMERS
consumers spend tremendous sums out of their own pockets on health care servicesfor
example, an estimated $40 billion on complementary medicine such as acupuncture and
meditationthat many traditional medical providers believe to be of dubious value. Armed
with information gleaned from the Internet, such consumers disregard medical advice they
dont agree with, choosing, for example, to shun certain drugs doctors have prescribed. A
company that recognizes and leverages consumers growing sense of empowerment, and
actual power, can greatly enhance the adoption of an innovation.
ACCOUNTABILITY
Increasingly, empowered consumers and cost-pressured payers are demanding accountability
from health care innovators. For instance, they require that technology innovators show costeffectiveness and long-term safety, in addition to fulfilling the shorter-term efficacy and
safety requirements of regulatory agencies.
35
INNOVATION IN HEALTHCARE
While stakeholders need to constantly focus on these aspects to drive long-term frugal
innovations, concerted efforts are also required to strengthen factors that significantly
contribute to building an environment of sustainabilityIMPROVEMENTS IN TECHNOLOGY
Technology in the last two decades has revolutionized the way healthcare is delivered. The
use of customized technology has the potential to impact patients and providers alike by
enhancing the quality of delivery, reduction in turnaround time of workflows and thus the
overall cost, besides bringing in higher accountability into the system. Illustrations of
customized technological advancements that have already been implemented include
telemedicine, tele-monitoring, HMIS, m-health, smart cards, mobile clinical devices and the
use of palmtops.
IMPROVEMENT IN QUALITY OF HUMAN RESOURCES
To support technological developments, policy makers and industry leaders would also need
to focus on availability and quality of human resources with suitable skill sets and appropriate
deployment at different levels of the health care set-up: private and public, urban and rural,
and prevention and cure.
36
INNOVATION IN HEALTHCARE
37
INNOVATION IN HEALTHCARE
CONCLUSION
Change is the only constant in today's world and every industry has to innovate and invest in
new technologies and ideas in order to grow and sustain in the ever changing markets.
Healthcare is no exception to this. However, successful innovations cannot be managed like
ordinary business functions with traditional management controls. They should be fostered
and nurtured in an environment which is radically different from the existing business
settings.
People-Process-Technology are the driving forces for Innovation in the Healthcare Industry.
Proper balance between these forces ensures sustainability and overall success of the
innovation briefly carried on. Besides on through check Technology and People play a major
role in Innovation. Technology aids and the processing and utilization of human resource can
make any Innovation into a major success.
Cost, Pricing, Funding, Cross-country barriers can be easily overcome with proper blend of
technology implementation and proper Delivery system. Also efficient marketing strategies
will ensure overall achievements of the targets and successful innovation implementation.
38
INNOVATION IN HEALTHCARE
REFERENCES
August 2007
Innovative and sustainable healthcare management: Strategies for growth, Deloitte
Website:
http://pwc.com
http://deloitte.com
http://en.wikipedia.org
39